Prange Karen has filed 10 insider transactions across 3 companies since February 2023.
Most recent transaction: a grant/award of 22841 shares of Embecta Corp. ($EMBC) on February 11, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Embecta Corp. | $EMBC | Prange Karen | Director | A | Common Stock | 22841 | $0.00 | 64,581.2080 | 59,290,000 | 54.72% | 0.04% |
| Jan. 9, 2026 | Outset Medical, Inc. | $OM | Prange Karen | Director | A | Common Stock | 18667 | $0.00 | 18,667.0000 | 18,153,090 | 9999.99% | 0.10% |
| May 19, 2025 | AtriCure, Inc. | $ATRC | Prange Karen | Director | A | Common Stock | 5401 | $0.00 | 23,229.0000 | 48,879,604 | 30.30% | 0.01% |
| March 5, 2025 | AtriCure, Inc. | $ATRC | Prange Karen | Director | S | Common Stock | 6100 | $38.12 | 17,828.0000 | 48,879,604 | 25.49% | 0.01% |
| Feb. 12, 2025 | Embecta Corp. | $EMBC | Prange Karen | Director | A | Common Stock | 13839 | $0.00 | 39,743.1970 | 58,622,000 | 53.42% | 0.02% |
| May 13, 2024 | AtriCure, Inc. | $ATRC | Prange Karen | Director | A | Common Stock | 7788 | $0.00 | 23,928.0000 | 0 | 48.25% | 0.00% |
| Feb. 7, 2024 | Embecta Corp. | $EMBC | Prange Karen | Director | A | Common Stock | 11455 | $0.00 | 24,897.9020 | 57,758,000 | 85.21% | 0.02% |
| June 8, 2023 | AtriCure, Inc. | $ATRC | Prange Karen | Director | S | Common Stock | 713 | $47.89 | 16,140.0000 | 0 | 4.23% | 0.00% |
| May 25, 2023 | AtriCure, Inc. | $ATRC | Prange Karen | Director | A | Common Stock | 3186 | $0.00 | 16,853.0000 | 0 | 23.31% | 0.00% |
| Feb. 9, 2023 | Embecta Corp. | $EMBC | Prange Karen | Director | A | Common Stock | 6979 | $0.00 | 13,068.8229 | 0 | 114.60% | 0.00% |